Objective: The present work aimed to retrospectively assess the outcomes associated with decortication by video-assisted thoracic surgery (VATS) in patients with tuberculous empyema. Methods: Patients (n = 274) who underwent decortication by VATS for surgical management of pleural empyema between January 2000 to 2010 were included. Pre-, intra-, and postoperative characteristics were observed for all patients, which were followed up for 12 months to evaluate surgical outcomes such as postoperative complications and disease recurrence. Results: No patients required conversion to thoracotomy, and no death or postoperative bleeding was reported. The mean operation time was 104.5 ± 20.4 min, with 271.5 ± 41.3 ml intraoperative blood loss and median length of hospital stay of 7.2 ± 3 .4 days. Of the 274 patients, 262 were followed up for 12 months; 26 (9.9%) patients showed complications, including incomplete lung re-expansion (11 patients) and persistent air leak (6 patients). While early disease recurrence was observed in 3 (1.1%) patients after surgery, late recurrence was reported for 6 (2.3%) individuals. Interestingly, the complication rate was much higher in patients with chronic empyema (15/34, 44.1%) than in subjects with acute empyema (11/228, 4.8%). Conclusions: Decortication by VATS decreases postsurgical complications, and results in decreased disease recurrence. This study demonstrated improved outcomes by decortication by VATS, even in patients with stage III tuberculous empyema.
Introduction
Pleural tuberculosis is the most common presentation of extra-pulmonary tuberculosis and pleural effusion worldwide. 1) Tuberculous empyema thoracis usually occurs when caseous material from a superficial parenchymal cavity ruptures into the pleural space. It may also develop by: (1) secondary paratracheal lymph node involvement (2) direct extension of a paravertebral cold abscess, (3) progression of a primary tuberculous pleural effusion itself, or (4) hematogenous spread of infection. 2) Untreated or inadequately treated tuberculous empyema may result in empyema necessities, which often appears as bronchopleurocutaneous fistula.
Surgical management has become a mandatory treatment option for patients with tuberculous empyema: it helps diagnose the disease condition, recover from the infection, allow the affected lung to re-expand, and prevent subsequent chronic respiratory impairments. Though different surgical modalities are available for managing primary empyema, video-assisted thoracic surgery (VATS) is considered an effective procedure in the early stages of empyema thoracis. 3, 4) As previously reported, decortication by VATS can be touted as the surgical treatment of choice for chronic post-pneumonic pleural empyema. 5) With decortication by VATS attracting increasing attention, it is imperative to assess its surgical outcomes through clinical studies with large sample size. Therefore, the present study aimed to explore the outcomes and complications associated with decortication by VATS, by retrospectively analyzing 274 patients with tuberculous empyema who underwent this procedure at a single Chinese center over a period of 10 years.
Materials and Methods

Study Patients
Data collected from patients who underwent decortication by VATS for surgical management of tuberculous empyema between January 2000 and January 2010 at the department of thoracic surgery in TaiZhou hospital (LinHai, China) were retrospectively analyzed (Supplemental Fig. 1) . Of the 738 patients suffering from pleural empyema, individuals with pleural effusion who fulfilled at least one of the following criteria were included in this study: (i) sputum culture positive for acid fast bacilli stain or (ii) pathological confirmation of the disease (Supplemental Fig. 2) . The empyema disease stage was determined by assessing the quality of the underlying parenchyma. 6) Posteroanterior (PA) chest and lateral chest x-ray, and thoracic computed tomography (CT) scan were obtained from all patients.
Post-pneumonic empyema cases were divided into three stages based on disease development: 3) stage I is an exudative phase characterized by a clear, thin, and sterile pleural effusion; stage II represents a transitional or fibrinopurulent phase, in which the fluid becomes thick, infected, and purulent; stage III is an organizing or consolidation phase, which involves the formation of granulation tissue and lung encasement.
Surgical Indications and Procedure
Surgical treatment was indicated for patients who had either of the following medical conditions: (1) a simple chest drainage became inadequate; (2) chest CT scan revealed extensive adhesion, separation, fiberboard, and incomplete lung re-expansion; and (3) unclear diagnosis of pleural effusion.
For surgery, patients were placed in lateral position, and the procedure was carried out under general anesthesia, with a double-lumen tube for selective ventilation (Supplemental Fig. 3 ). An observational hole was generated in the abscess cavity, together with two operation holes. After obtaining a clear view of the pleural fiberboard, a 22 cm long, curved vascular clamp was directly inserted into the chest cavity. A small fiberboard was torn initially till the surface of normal lung and extended to the surrounding strip, or flake avulsion was induced until the fiber completely stripped, allowing the lung to re-expand. Next, the adhesion between the parietal pleural peel and diaphragm was stripped ( Supplemental  Fig. 4 ). An argon beam coagulator was used in case of bleeding or leakage and a chest drainage tube was placed through the observational hole. A flush pipe was also placed, when necessary. About 1 to 2L normal saline was supplied to the thoracic cavity through the flush pipe, 3 to 7 days after surgery.
Postoperative management
After surgery the drainage bottle was emptied by negative pressure, and the changes in volume and color of chest drainage, breath sounds, and surgical incision were observed. Successful outcome was characterized by the following: (1) water-sealed bottle without any escape of air bubbles and (2) chest X-ray or CT scan indicating fully re-expanded lung without persistent space, with drainage of <100 ml/24 h, and fading drainage fluid color. Patients were treated for 9 months with anti-tuberculosis regimen: isoniazid, rifampicin, pyrazinamide, and ethambutol for 2 months, followed by isoniazid and rifampicin for the next 7 months. Patients were followed up for 12 months in outpatient clinic with blood tests, chest X-ray, and liver function assessment.
Statistical analyses
Statistical analyses were performed using the SPSS software for Microsoft Windows (version 19.0, SPSS Inc., Chicago, IL). Descriptive values were expressed as mean ± standard deviation (SD) and median (range). Normally distributed data were analyzed by one-way analysis of variance (ANOVA). Non-normally distributed data were analyzed by the non-parametric Rank Sum Test. A P value of <0.05 was considered statistically significant.
Results
Preoperative characteristics
A total of 274 patients (male: 149, female: 125) with median age of 42 years (range: 6 to 83) underwent ( Table 3 ). The most common complication was incomplete lung re-expansion, which developed in 11 patients (4.2%). However, they were all cured by enhanced coughing training and drainage. Prolonged air leak was recorded in 6 patients (2.3%), who were cured by prolonged drainage and enhanced nutrition ( Table 3 ). All other postoperative complications were improved by symptomatic treatment.
Disease recurrence
Disease relapse, including the progression to tuberculous empyema necessitates re-effusion and surgical site infection were observed during the follow up. Among the 262 patients followed-up, no disease relapse was reported in 236 subjects, including 217 stage I-II (95.2%) and 19 stage III (48.7%) patients. Early recurrence was reported in three cases. Two of them showed elevated temperatures (38.5 to 39.5°C) for 4 to 6 days after operation, and their chest CT scan indicated tuberculous abscess fistula. Both patients required a second decortication by VATS for recovery. The third patient had re-effusion with fiberboard, decortication by VATS. They showed between 1 week and 2 years from the onset of symptoms to disease presentation. The common symptoms in patients included cough (90.9%, 249/274), chest tightness (79.6%, 218/274), chest pain (64.2%, 176/274), fever (37.6%, 103/274), and night sweat (34.7%, 95/274). Stage I, II, and III empyema were found in 78, 157, and 39 patients, respectively. While 129 patients had left lung empyema, 145 individuals were affected in the right lung ( Table 1) . There are 39 Stage III patients, all of whom had clinical manifestation and chest CT scan revealing extensive adhesion, separation, fiberboard, or incomplete lung re-expansion.
Intraoperative characteristics
No patients required conversion to thoracotomy and no mortality was reported in the study population ( Table 2) . The mean operation time was 104.5 ± 20.4 min (range: 40 to 180), with a mean blood loss of 271.5 ± 41.3 ml during surgery. Drainage was performed with a mean time of 5.4 ± 2.6 days after the decortication by VATS, and the mean hospital stay was 7.2 ± 3.4 days ( Table 2) .
The pathological changes of all patients were granulomatous inflammation and 114 cases showed positive acid fast bacilli stain.
Postoperative complications
No postoperative bleeding was observed in patients. After surgery, a mean drainage volume of 521.7 ± 104.2 ml was obtained ( Table 2) . A total of 262 patients were followed up for 2 to 12 months, a return rate of 95.6% which was cured by adding streptomycin to the antituberculosis regimen.
Late recurrence was reported in six patients, with re-effusion and surgical site infection recorded six months after surgery. Recurrence in these patients was confirmed with chest CT scan. These individuals received a secondary surgery, and the results of TB sputum smear switched to negative and albumin >32 g/L, under quadruple antituberculosis treatment.
Postoperative complications with respect to disease severity
In the present study, decortication by VATS was indicated for both acute empyema (stages I and II) and chronic empyema (stage III) patients. In 262 patients with follow-up data, the complication rate was much higher in patients with chronic empyema (15/34, 44.1%) in comparison with that of acute empyema individuals (11/228, 4.8%) (P <0.001). More patients were reported with incomplete lung re-expansion, persistent air leak, and late recurrence in the chronic empyema subgroup than in the acute disease subgroup (1.8 vs. 20.6%, 0.9 vs 11.8%, 0.4 vs. 0.9%, respectively; P <0.001). However, there was no significant difference observed between the two groups for early recurrence (P = 0.29) ( Table 4) .
Discussion
Clinical outcomes in tuberculous empyema are generally worse than in non-tuberculous etiologies due to concomitant fibrocavitary parenchymal disease, frequent bronchopleural fistulae, and poor general condition of patients; indeed, these patients may suffer from thorax collapse, intercostal space narrowing, and scoliosis. 7) Most early tuberculous empyema cases can be cured by anti-tuberculosis regimen, thoracentesis, and thoracic drainage. However, patients with chronic empyema often require a long course of treatment and surgery.
To date, decortication by VATS has been used as alternative for open pneumothorax surgery. In contrast to conventional open surgery, decortication by VATS separates adhesions within the chest, absorbs fluid and empyema, eliminates fiber separation, pus, and necrotic tissue, strips pleural fiber to promote lung recruitment, obliterates dead space, shortens the recovery period, and maximize lung function recovery. Cardillo, et al compared the clinical outcomes of open thoracotomy decortication and decortication by VATS and demonstrated the latter to be better in terms of inpatient hospital stay, pain, postoperative air leak, operative time, and time to return to work. 5) Meanwhile, median operative times of 86, 90, and 75 min were obtained for VATS, thoracotomy, and minithoracotomy, respectively, with median total length of stay (LOS) of 15, 20.5 and 21 days, respectively; median preoperative LOS was longer for thoracotomy (10 days) compared with VATS (5 days) or mini-thoracotomy (1 day), while median postoperative LOS was longer for VATS (14 days) in comparison with thoracotomy (9.5 days) and mini-thoracotomy (8 days). 8) The LOS reported herein was 7.2 days, almost half of that of Karen, et al, though we observed longer operative time (104.5 ± 20.4 min). However, Casali, et al demonstrated that decortication by VATS had shorter postoperative hospital stay and chest drainage duration than thoracotomy; in addition, decortication by VATS showed higher improvement in subjective dyspnea degree. 9) The results presented herein are consistent with this report, with respect to postoperative hospital stay. Interestingly, it was reported that despite wide use of decortication by VATS in drainage easing, significant practical benefits such as rib crowding and pleural symphysis could not be obtained in this setting. 10) Patients undergoing decortication by VATS are reported to have fewer postoperative complications. The five-year survival rate of VATS was reported to be higher than that of thoracotomy in a retrospective cohort study. 11) Herein, complications were recorded only in 26 patients (9.9%), while 236 individuals (90.1%) recovered after surgery. A previous study found a mortality rate of 1.29% (4/308), with 21.1% (65/308) morbidity; at six months follow up, open thoracotomy decortication in three patients showed recurrent empyema, who underwent repeated surgery by VATS (one patient) or thoracotomy (two patients). 5) In addition, it was reported that four patients with empyema, who underwent thoracoplasty died because of respiratory failure, while seven others died from various causes. 12) Interestingly, no mortality was recorded in the present study, suggesting the safety of this procedure. Indeed, the 236 patients who were followed up (two months to one year) did not show disease relapse, and postoperative complications were improved by active and symptomatic treatments.
The main causes of pulmonary atelectasis and cavity include ineffective fiberboard stripping and antituberculosis treatment, and sputum plug. It is also beneficial to raise the diaphragm, shift mediastinum, and eliminate the residual cavity.
Early recurrence may occur due to incomplete stripping of the fiberboard, with the tube withdrawn too early, which causes incomplete lung re-expansion and ineffective anti-tuberculosis treatment. Delayed recurrence are caused by many factors: (i) the initial pleura infection by Mycobacterium tuberculosis (before the operation) continues in pleural cavity and causes tuberculous empyema 13) ; (ii) the visceral pleura and lung tissue may be damaged during the operation, and the fiberboard not adequately stripped, especially the reflexed part; (iii) ineffective antituberculosis treatment after the operation, which may lead to drug-resistant tuberculosis. If the pleural effusion is not actively treated, it would cause pleural calcification and lead to serious impact on lung function (Supplemental Fig. 5 ). An infected surgical site can be cured by active dressing, appropriate anti-tuberculosis treatment, or a second decortication by VATS.
Several studies have shown that VATS is effective in the early stages of empyema thoracis (fibrino-purulent stage or stage II). 3, 10, [14] [15] [16] [17] In the current study, the lung re-expansion could not be achieved effectively for patients with a disease course of more than one month. When the conservative treatment becomes ineffective in 1 to 2 months, it is essential to completely strip the pleura fiberboard by VATS; for disease course prolonging to more than three months, it would be difficult to strip the pleura fiberboard; in the late phase of the pleural infectious process, when a thick pleural peel encases the lung, a pulmonary decortication is required and open approach is often needed. 18) Open surgery is considered an indication for stage III empyema due to the complexities associated with the disease. However, it remains unclear whether VATS is more useful in such advanced disease stage, since more studies with large patient pool are required to support the data obtained in isolated clinical observations. 19, 20) It was suggested that VATS for tuberculous empyema is effective only for stage II disease, and open thoracotomy and decortication are indicated for stage III empyema. 19) The conversion and reoperation rates were low for early stages, suggesting the thoracoscopic approach as effective and reasonable first option for most patients with complex pleural effusions and empyema. 21) Based on the 10-year experience obtained in this study, it could be recommended that even thick fibers (1-2 cm) could be applied to decortication by VATS. A total of 34 patients (disease duration greater than 5 months) in stage III were cured after decortication by VATS in the present study. However, the complications in stage III cases (15/34, 44.1%) were higher compared with other individuals (11/228, 4.8%). This might result from: (1) the long disease course in patients that causes poor nutritional status and decreased immune function; (2) long-term pleural effusion and lung parenchyma injury are prone to intraoperative damage; (3) difficulty in stripping the fiberboard in patients with thickened fiberboard and easily damaged peripheral tissue; (4) possibility of drug resistance during anti-tuberculosis treatment. The inadequate stripping of the fiberboard might be the main cause of early recurrence. In the future clinical practice, we will be more strictly to screen the patients, especially who are elder and not associated with active disease or serious clinical symptoms, for decortication by VATS, in order to reduce the postoperative complications.
Conclusions
Thoracoscopy is a safe and effective approach for the diagnosis and treatment of tuberculosis or its complications. Patients undergoing decortication by VATS show less postoperative complications. Therefore, decortication by VATS can help improve the outcomes in stage III empyema. In agreement with many reports, this minimally invasive approach appears to be the treatment of choice for tuberculous empyema. More multi-centered, randomized clinical trials are needed to validate these findings, which would make decortication by VATS the gold standard for the treatment of tuberculous empyema.
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